Clinical Trial Update: Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial of pemetrexed plus carboplatin in locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 2 | Status: COMPLETED